Flutemetamol F-18
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Discordance in amyloid positivity between visual reads and Centiloids: Impact of white matter uptake.
Journal: The journal of prevention of Alzheimer's disease
Published: December 20, 2025
Machine learning-based prediction of amyloid positivity using early-phase F-18 flutemetamol PET.
Journal: Journal of Alzheimer's disease : JAD
Published: June 24, 2025
Tau PET probes for Alzheimer's disease detection and their structural characterization.
Journal: Advances in protein chemistry and structural biology
Published: May 05, 2025
Role of Amyloidogenic and Non-Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents.
Journal: Chembiochem : a European journal of chemical biology
Published: March 11, 2024
Accuracy of Injection Dose of Amyloid PET Agent Using Radiopharmaceutical Activity Suppliers
Journal: Nihon Hoshasen Gijutsu Gakkai zasshi
Published: December 10, 2023
Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients.
Journal: Radiology and oncology
Published: October 12, 2021
Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative.
Journal: Clinical nuclear medicine
Published: April 22, 2021
Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain.
Journal: Nuclear medicine and biology
Published: February 25, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
Journal: Brain : a journal of neurology
Published: August 20, 2019
Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography.
Journal: Annals of nuclear medicine
Published: May 16, 2019
Last Updated: 04/28/2026